Share

Search your stocks

Ctrl+K

VILINBIOVilin Bio Med Ltd.

25.5(+0.00%)

1W: -4.49%

1M: -5.90%

1Y: +10.87%

Vilin Bio Med Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 10% in the latest quarter indicates strong demand for products.
Operating margin improved to 15%, showcasing enhanced operational efficiency.
Investment in R&D increased by 20%, signaling commitment to innovation and long-term growth.

NEGATIVES

Net profit decreased by 5% compared to the previous quarter, raising concerns over profitability.
Debt levels rose by 8%, indicating potential liquidity issues.
Inventory turnover rate declined, suggesting inefficiencies in supply chain management.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-